Kiora Pharmaceuticals Inc... (KPRX)
NASDAQ: KPRX
· Real-Time Price · USD
2.93
0.40 (15.81%)
At close: Aug 15, 2025, 3:59 PM
2.90
-1.02%
After-hours: Aug 15, 2025, 07:46 PM EDT
Kiora Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | 20K | 16M | 283.87K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 31.5K | 19.61K | 34.09K | 14.23K | 17.88K | 16.21K | 7.93K | 42.38K | 56.7K | 42.86K | 10.29K | 36.6K | 567.23K | 61.88K | 59.5K | 58.18K | 59.5K | 50.09K |
Gross Profit | -31.5K | -19.61K | -15.99M | -14.23K | -886.68K | 15.98M | 275.94K | -1.09M | -56.7K | -42.86K | -10.29K | -36.6K | -567.23K | -61.88K | -59.5K | -58.18K | -59.5K | -50.09K |
Operating Income | -2.4M | -2.33M | -2.56M | -3.6M | -2.54M | 13.21M | -2.12M | -5.92M | -2.63M | -1.92M | -2.63M | -3.7M | -2.4M | -3.57M | -8.65M | -2.97M | -2.75M | -2.58M |
Interest Income | 225.24K | 276.63K | 438.86K | 248.84K | 342.1K | 223.05K | 45.52K | 49.91K | 45.09K | 33.47K | 56.89K | 7.86K | 1.24K | 217.00 | 300.00 | 259.00 | 332.00 | 250.00 |
Pretax Income | -2.26M | -2.07M | -2.16M | -3.41M | -2.22M | 13.45M | -2.18M | -5.76M | -2.61M | -1.87M | -2.61M | -5.12M | -2.4M | -3.57M | -8.68M | -2.97M | -2.47M | -2.58M |
Net Income | -2.15M | -2.19M | -4.22M | -3.41M | -2.22M | 13.45M | -2.27M | -5.76M | -2.61M | -2.24M | -2.72M | -6.54M | -2.4M | -3.56M | -8.38M | -2.97M | -2.47M | -2.58M |
Selling & General & Admin | 1.35M | 1.49M | 1.33M | 1.38M | 1.54M | 1.28M | 872.62K | 1.42M | 1.1M | 1.27M | 2.78M | 2.03M | 1.8M | 1.66M | 1.38M | 1.34M | 1.31M | 1.3M |
Research & Development | 2.59M | 2.53M | 4.12M | 1.32M | 906.68K | 1.49M | 1.11M | 1.09M | 1.39M | 438.28K | 841.62K | 1.33M | 567.23K | 707.93K | 1M | 1.63M | 1.44M | 1.28M |
Other Expenses | n/a | -4.22M | -6.22M | 904.01K | -786.45K | n/a | -2.37M | 2.33M | -25.89K | 14.67K | n/a | 937.00 | 32.94K | 1.2M | 6.27M | n/a | n/a | n/a |
Operating Expenses | 3.94M | -201.53K | -773.38K | 3.6M | 1.66M | 2.77M | -387.29K | 4.83M | 2.49M | 1.71M | 3.62M | 3.37M | 2.37M | 2.37M | 2.38M | 2.97M | 2.75M | 2.58M |
Interest Expense | n/a | n/a | 21.45K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 738.00 | n/a | n/a | n/a | 4.13K | n/a | 2.03K | 686.00 |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -16.21K | -7.93K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.26M | 2.33M | 2.56M | 3.6M | 2.56M | 2.79M | 2.12M | 5.92M | 2.49M | 1.71M | 3.62M | 3.37M | 2.37M | 2.37M | 2.38M | 2.97M | 2.75M | 2.58M |
Income Tax Expense | -112.06K | -123.01K | 2.07M | n/a | n/a | n/a | 90.32K | n/a | n/a | 369.72K | 113.01K | 1.42M | n/a | -4.43K | 304.78K | 259.00 | 2.03K | 250.00 |
Shares Outstanding (Basic) | 3.99M | 4.22M | 3M | 4.21M | 4.17M | 25.94M | 7.71M | 7.11M | 3.29M | 1.86M | 1.8M | 848.53K | 326.64K | 316.38K | 256.63K | 256.63K | 186.66K | 183.95K |
Shares Outstanding (Diluted) | 3.99M | 4.22M | 3M | 4.21M | 4.17M | 35.03M | 7.71M | 7.11M | 3.29M | 1.86M | 1.8M | 848.53K | 326.64K | 326.46K | 256.63K | 267.59K | 186.66K | 183.95K |
EPS (Basic) | -0.54 | -0.52 | -1.41 | -0.81 | -0.53 | 4.67 | -0.29 | -0.81 | -0.79 | -1.2 | -1.52 | -7.7 | -7.35 | -11.25 | -32.65 | -11.56 | -13.23 | -14.03 |
EPS (Diluted) | -0.54 | -0.52 | -1.41 | -0.81 | -0.53 | 3.46 | -0.29 | -0.81 | -0.79 | -1.2 | -1.52 | -7.7 | -7.35 | -10.91 | -32.65 | -11.09 | -13.23 | -14.03 |
EBITDA | -2.23M | -2.05M | -2.5M | -2.7M | -2.42M | 13.47M | -2.17M | -2.49M | -2.47M | -1.7M | -2.6M | -3.36M | -2.35M | -2.36M | -5.88M | -2.96M | -2.41M | -2.53M |
EBIT | -2.26M | -2.06M | -2.51M | -2.7M | -2.42M | 13.21M | -5.71M | -2.5M | -2.49M | -1.71M | -5.58M | -3.37M | -2.37M | -2.37M | -8.68M | -2.97M | -2.54M | -2.01M |
Depreciation & Amortization | 31.5K | 318.00 | 5.91K | 2.1K | 17.88K | 16.21K | 7.93K | 11.31K | 56.7K | 42.86K | 10.29K | 36.6K | 46.42K | 61.88K | 59.5K | 58.18K | 59.5K | 50.09K |